SCHEMBL7933625

SCHEMBL7933625

CC(C)CCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7935146 0.98
SCHEMBL16576103 0.83 LMNA (0.34) LMNA
SCHEMBL16576072 0.83 LMNA (0.34) LMNA
SCHEMBL16576098 0.83 LMNA (0.34) LMNA
SCHEMBL16576073 0.83 LMNA (0.34) LMNA
SCHEMBL16576099 0.83 LMNA (0.34) LMNA
SCHEMBL16576091 0.83 LMNA (0.34) LMNA
SCHEMBL30119945 0.83 LMNA (0.34) LMNA
SCHEMBL16576088 0.83 LMNA (0.34) LMNA
SCHEMBL16576071 0.83 LMNA (0.34) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230400764-A1 ORGANOMETALLIC COMPOUND COMPRISING A METAL COMBINED WITH AT LEAST ONE LIGAND CONTAINING FOUR OR MORE FLUORINE ATOMS, RESIST COMPOSITION COMPRISING THE SAME, AND METHOD OF FABRICATING SEMICONDUCTOR DEVICE USING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-12-14 US disclosed
US-9630981-B2 Processes for preparing functionalized F-POSS monomers NBD NANOTECHNOLOGIES, INC. (US) 2017-04-25 US disclosed
US-20160326191-A1 PROCESSES FOR PREPARING FUNCTIONALIZED F-POSS MONOMERS HENKEL AG & CO. KGAA (DE) 2016-11-10 US disclosed
WO-2010138807-A1 FLUORINATED SILYLETHYNYL PENTACENE COMPOUNDS AND COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME 3M INNOVATIVE PROPERTIES COMPANY (US) 2010-12-02 WO disclosed
US-6211248-B1 BIOCOMPATIBLE SOLVENT FOR PERFLUOROCARBONS AND HYDROCARBONS PHARM PUR GMBH (DE) 2001-04-03 US disclosed
EP-0877010-B1 Fluorinated alkanes and their uses PHARMPUR GMBH (DE) 2000-08-30 EP disclosed
EP-0877010-A1 Fluorinated alkanes and their uses PHARMPUR GmbH (DE) 1998-11-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230400764-A1 ORGANOMETALLIC COMPOUND COMPRISING A METAL COMBINED WITH AT LEAST ONE LIGAND CONTAINING FOUR OR MORE FLUORINE ATOMS, RESIST COMPOSITION COMPRISING THE SAME, AND METHOD OF FABRICATING SEMICONDUCTOR DEVICE USING THE SAME NR2C2, NR2F2, NR2E1 LMNA 4588/4885
US-20160326191-A1 PROCESSES FOR PREPARING FUNCTIONALIZED F-POSS MONOMERS PFAS, SFXN1, PFN1 LMNA 1299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.